Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · UT, MD, TX · Jul 2, 2015 → May 14, 2024
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:34 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Sunil Sharma is listed as an executive officer, director, and promoter on 15 SEC Form D filings by 5 issuers between Jan 2011 and May 2024: Stingray Therapeutics, Inc. (Dallas, TX — biotechnology — 2020–2024; $6.61M reported sold to 52 investors), Beta Cat Pharmaceuticals, Inc. (Houston, TX — pharmaceuticals — 2014–2017; $2.6M reported sold to 17 investors), ConverGene LLC (Gaithersburg, MD — biotechnology — 2014; $850K reported sold to 9 investors), Salarius Pharmaceuticals, LLC (Holladay, UT — pharmaceuticals — 2016; $775K reported sold to 8 investors) and Beta Cat Pharmaceuticals, LLC (Greenwood, IN — biotechnology — 2011; $275K reported sold to 7 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer, director, and promoter, over about 13 years. Across those companies the filings report $11.1M sold in total.
Listed alongside Jonathan P. Northrup (15 shared filings), Scott Andrew Jordan (4 shared filings), Uma Bhatt (4 shared filings), Alain Cappeluti (3 shared filings), David Bearss (3 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sunil. Each name links to their own page.
The issuers belong to 2 sponsor groups: Beta Cat Pharmaceuticals (2 issuers, $2.88M reported sold, 2011–2018) and Noble (2 issuers, $1.08M reported sold, 2012–2014).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 15 public filings for Sunil Sharma and found 17 differences, 5 worth asking the sponsor about: 28% of the money raised went to insiders; 62% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Sunil Sharma has not run yet — it is joining a line of 48,126 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:34 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Sunil Sharma..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
5 cases: 1 open, 4 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:34 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
17 differences found between the filings for Sunil Sharma — 5 worth asking about (compared 15 filings on Oct 24, 2026)
The Oct 13, 2020 Form D/A reports $117,272 sold and $32,500 of the proceeds used for payments to officers, directors or promoters.
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
The Aug 13, 2020 Form D reports $52,272 sold and $32,500 of the proceeds used for payments to officers, directors or promoters.
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
The Aug 13, 2020 Form D lists Scott Andrew Jordan as executive officer, director, promoter of the issuer and also as a person receiving sales compensation (CRD 4176591). Sales commissions reported on this filing: $32,500.
What this means The same person is listed as running the company and as being paid to sell its securities. Ask how much and on what terms.
Beta Cat Pharmaceuticals, Inc. (last filing Jun 27, 2018; $2,600,000 sold of $6,000,000); Salarius Pharmaceuticals, LLC (last filing Nov 21, 2016; $775,000 sold of $2,745,000); Beta Cat Pharmaceuticals, LLC (last filing Jan 6, 2011; $275,000 sold of $3,000,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
Liberi Life Sciences Consultancy BV is listed as receiving sales compensation on 3 filings (Aug 13, 2020 to May 26, 2021) with no FINRA CRD number given.
What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.
Form D filed 67 days after the first sale — Stingray Therapeutics, Inc. · Form D filed 511 days after the first sale — Beta Cat Pharmaceuticals, Inc. · Form D filed 975 days after the first sale — Salarius Pharmaceuticals, LLC · Form D filed 1,341 days after the first sale — Salarius Pharmaceuticals, LLC · Form D filed 340 days after the first sale — Salarius Pharmaceuticals, LLC · and 3 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — Stingray Therapeutics, Inc. (latest filing May 14, 2024) · No amendment in the last 12 months on an offering that may still be open — Stingray Therapeutics, Inc. (latest filing Feb 2, 2024) · No amendment in the last 12 months on an offering that may still be open — Stingray Therapeutics, Inc. (latest filing Dec 28, 2023) · No amendment in the last 12 months on an offering that may still be open — Stingray Therapeutics, Inc. (latest filing May 26, 2021) · No amendment in the last 12 months on an offering that may still be open — Salarius Pharmaceuticals, LLC (latest filing Apr 4, 2016) · and 3 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The May 26, 2021 filing lists Sunil Sharma as executive officer, director, promoter; the Mar 31, 2023 Form D lists executive officer, director.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Apr 4, 2016 filing lists Sunil Sharma as director, promoter; the Nov 21, 2016 Form D lists executive officer, director, promoter.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Mar 31, 2023 filing says $5,230,297 offered; the Dec 28, 2023 Form D/A says $6,668,926.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Oct 13, 2020 filing says $1,500,000 offered; the May 26, 2021 Form D/A says $3,000,000.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
"Biotechnology" (Jul 8, 2014 to Jul 2, 2015); then "Pharmaceuticals" (Dec 18, 2017).
What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.
"Decline to Disclose" (Jul 8, 2014); then "No Revenues" (Dec 18, 2017).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
This page covers filings where the address state is UT or MD or TX. A separate record, "Sunil Sharma" with address state A1, is listed on 1 filing — most recently by Zacapa Resources Ltd. (Jul 19, 2023). Both records have filings in the same period (Jul 19, 2023).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Mar 31, 2023 filing give Houston, TX; on the Dec 28, 2023 filing they give Dallas, TX.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Jul 8, 2014 filing give Gaithersburg, MD; on the Jul 2, 2015 filing they give Houston, TX. The address now on file (2450 West Holcombe Blvd, Houston, TX) is a registered-agent or shared-office address used by 25 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
UT on 4 filings (Jan 6, 2011 to Nov 21, 2016); MD on 2 filings (Apr 8, 2014 to Jul 8, 2014); TX on 9 filings (Jul 2, 2015 to May 14, 2024).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
1 of 12 offerings reports sales commissions totalling $32,500; 1 reports finder's fees totalling $29,500; 2 report proceeds to related persons totalling $157,500. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| May 14, 2024 D Stingray Therapeutics, Inc. File 021-513216 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 2, 2024 D Stingray Therapeutics, Inc. File 021-504213 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 28, 2023 D/A Stingray Therapeutics, Inc. File 021-477596 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 26, 2021 D/A Stingray Therapeutics, Inc. File 021-373125 | $32,500 | $29,500 (est.) | $32,500 | Scott Andrew Jordan BrokerCheck CRD 4176591 ↗ via Finalis Securities LLC (CRD 305908 ↗) Liberi Life Sciences Consultancy BV no CRD number reported | EDGAR ↗ |
| Dec 18, 2017 D Beta Cat Pharmaceuticals, Inc. File 021-301052 | $0 | $0 | $125,000 (est.) | N/A no CRD number reported | EDGAR ↗ |
| Nov 21, 2016 D Salarius Pharmaceuticals, LLC File 021-274897 | $0 | $0 | $0 Proceeds will be used for working capital, which may include normal compensation to executive officers/managers. | None listed on this filing | EDGAR ↗ |
| Nov 21, 2016 D Salarius Pharmaceuticals, LLC File 021-274899 | $0 | $0 | $0 Proceeds will be used for working capital, which may include normal compensation to executive officers/managers. | None listed on this filing | EDGAR ↗ |
| Apr 4, 2016 D Salarius Pharmaceuticals, LLC File 021-260594 | $0 | $0 | $0 Proceeds will be used for working capital, which may include normal compensation to executive officers/managers. | None listed on this filing | EDGAR ↗ |
| Jul 2, 2015 D Beta Cat Pharmaceuticals, Inc. File 021-243016 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 8, 2014 D Beta Cat Pharmaceuticals, Inc. File 021-220563 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 8, 2014 D ConverGene LLC File 021-215153 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 6, 2011 D Beta Cat Pharmaceuticals, LLC File 021-153083 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Sunil Sharma on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $6.61M from 52 investors (100% of the $5M target) as of the latest filing. Sunil is listed as executive officer, director, promoter on 7 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $2.6M from 17 investors (100% of the $1.4M target) as of the latest filing. Sunil is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $775K from 8 investors (100% of the $132K target) as of the latest filing. Sunil is listed as executive officer, director, promoter on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $850K from 9 investors (85% of the $1M target) as of the latest filing. Sunil is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $275K from 7 investors (9% of the $3M target) as of the latest filing. Sunil is listed as executive officer, promoter.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
Jonathan P. Northrup is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
Kenneth Carter is on 8 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
David Bearss is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
Casey Cunningham is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Sunil Sharma. Their page shows their other deals.
One team, 2 deal companies. Sunil Sharma is listed on 2 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Sunil Sharma.
One team, 2 deal companies. Sunil Sharma is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Sunil Sharma.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 5 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Sunil Sharma by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 5 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Sunil Sharma is listed on: none on file. No website or social profile named in ConverGene LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #318,628 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Gaithersburg, MD). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Sunil Sharma appears on a new Form D, or when a court case or SEC action is matched to them. See plans →